Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

PTC Therapeutics Inc. : PTC THERAPEUTICS PRICES INITIAL PUBLIC OFFERING

06/21/2013 | 05:03am US/Eastern
Recommend:
0

SOUTH PLAINFIELD, NJ - June 20, 2013 - PTC Therapeutics, Inc. (PTC) today announced the pricing of its initial public offering of 8,372,000 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts. All of the shares in the offering are being sold by PTC. In addition, the underwriters have an option for a period of 30 days to purchase up to 1,255,800 additional shares of common stock from PTC at the public offering price, less the underwriting discount. PTC's common stock has been approved for listing on the NASDAQ Global Select Market and is expected to begin trading under the ticker symbol "PTCT" on June 20, 2013.

J.P. Morgan and Credit Suisse are acting as joint book-running managers for the offering. Cowen and Company is acting as co-lead manager and Wedbush PacGrow Life Sciences as co-manager.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on June 19, 2013.

The offering is being made only by means of a prospectus, copies of which may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717; telephone: 866-803-9204; or Credit Suisse Securities (USA) LLC, Attn: Prospectus Department, One Madison Avenue, New York, NY 10010; telephone: 800-221-1037; email: newyork.prospectus@credit-suisse.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.

ABOUT PTC THERAPEUTICS, INC.

PTC is a biopharmaceutical company focused on the discovery and development of orally administered small-molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are of central importance to proper cellular function. PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare genetic disorders and infectious diseases.

CONTACT

Jane Baj

PTC Therapeutics, Inc.

908-912-9167

jbaj@ptcbio.com

Sheryl Seapy

Pure Communications

sheryl@purecommunicationsinc.com


distributed by
Recommend :
0
React to this article
Latest news
Date Title
<1m ago ALINGS AL NOOR HOSPITALS : Says Maksar Sells Shares (DIRECTOR DEALINGS)
<1m ago INDIA CEMENTS : to spin off IPL team CSK
<1m ago ENDOCYTE : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
1m ago FORD MOTOR : loses bid to recoup $450 million interest on overpaid taxes
1m ago GOOGLE 'C' : to do 3D mapping of Karnataka's monuments
1m ago SHIRE : Other Events, Financial Statements and Exhibits (form 8-K)
2m ago GM, Chrysler lead a strong US industry in September thanks to deals on pickup trucks
2m ago SAUDI ELECTRICITY : signs $682.5mn Riyadh metro deal
3m ago Smarsh Introduces Enhanced Archiving Support for Instagram
3m agoDJLONDON MARKETS : Supermarkets Sainsbury, Tesco Under Pressure In London
Latest news
Advertisement
Hot News 
AVINGTRANS : Profit Up On Acquisitions; Working To Improve Weak Units
SIGMA CAPITAL : GBP65m housing deal for Sigma as it regenerates itself into a developer
ANGIE LIST : Announces Date of Earnings Release and Conference Call for Third Quarter 2014 Financial Results
ACUITY BRANDS : Reports Record Fiscal 2014 Fourth Quarter and Full-Year Results
BABCOCK & WILCOX : B&W Evaluating a Separation of Its Businesses
Most Read News
1d ago BANK OF NEW YORK MELLON : BNY Mellon to shut derivatives sales, trading business
1d ago Microsoft names next operating system 'Windows 10'
1d ago EP ENERGY : CFO to Present at Deutsche Bank Finance Conference
1d ago DUKE REALTY : Announces Third Quarter Earnings Conference Call; Thursday, October 30th, 2014 at 3:00 p.m. ET
1d ago ENCANA : ATHLON ENERGY INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
Most recommended articles
<1m ago FORD MOTOR : loses bid to recoup $450 million interest on overpaid taxes
3m agoDJLONDON MARKETS : Supermarkets Sainsbury, Tesco Under Pressure In London
7m agoDJJ.P. Morgan Expects $869 Million in Credit for Consumer Mortgage Actions
9m agoDJEuro Remains Under Pressure as Recovery Slows -- 2nd Update
10m agoDJEUROPE MARKETS : European Stocks, Euro Fall After Fresh Round Of Dreary Data
Dynamic quotes  
ON
| OFF